Indication
Agents for the Sensory System
2 clinical trials
2 products
Product
CYNK-001Clinical trial
A Phase I Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK 001) in Multiple Myeloma Patients Following Autologous Stem Cell Transplant in the Front-line Setting.Status: Active (not recruiting), Estimated PCD: 2023-01-31
Clinical trial
An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant DepressionStatus: Completed, Estimated PCD: 2024-05-17
Product
VTS-K